BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24862872)

  • 1. Cyclin D1 gene amplification is highly homogeneous in breast cancer.
    Burandt E; Grünert M; Lebeau A; Choschzick M; Quaas A; Jänicke F; Müller V; Scholz U; Bokemeyer C; Petersen C; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Wilczak W
    Breast Cancer; 2016 Jan; 23(1):111-119. PubMed ID: 24862872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
    Mrhalová M; Kodet R; Strnad P
    Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    Ortiz AB; Garcia D; Vicente Y; Palka M; Bellas C; Martin P
    PLoS One; 2017; 12(11):e0188068. PubMed ID: 29140993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
    Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
    Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
    Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
    Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMSY and CCND1 amplification in familial breast cancer: from the Ontario site of the Breast Cancer Family Registry.
    Bane AL; Mulligan AM; Pinnaduwage D; O'Malley FP; Andrulis IL
    Breast Cancer Res Treat; 2011 Jun; 127(3):831-9. PubMed ID: 21327470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of CCND1 , C-MYC , and FGFR1 amplification using modified SYBR Green qPCR and FISH in breast cancer.
    Azarnezhad A; Tabrizi M; Javan F; Mehdipour P
    Turk J Med Sci; 2018 Aug; 48(4):759-767. PubMed ID: 30119151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
    Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
    Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis.
    Reis-Filho JS; Savage K; Lambros MB; James M; Steele D; Jones RL; Dowsett M
    Mod Pathol; 2006 Jul; 19(7):999-1009. PubMed ID: 16648863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPFIA1 and CCND1 are frequently coamplified in breast cancer.
    Dancau AM; Wuth L; Waschow M; Holst F; Krohn A; Choschzick M; Terracciano L; Politis S; Kurtz S; Lebeau A; Friedrichs K; Wencke K; Monni O; Simon R
    Genes Chromosomes Cancer; 2010 Jan; 49(1):1-8. PubMed ID: 19787783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
    Elsheikh S; Green AR; Aleskandarany MA; Grainge M; Paish CE; Lambros MB; Reis-Filho JS; Ellis IO
    Breast Cancer Res Treat; 2008 May; 109(2):325-35. PubMed ID: 17653856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-amplification of CCND1 and EMSY is associated with an adverse outcome in ER-positive tamoxifen-treated breast cancers.
    Brown LA; Johnson K; Leung S; Bismar TA; Benítez J; Foulkes WD; Huntsman DG
    Breast Cancer Res Treat; 2010 Jun; 121(2):347-54. PubMed ID: 19636701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.
    Stahl P; Seeschaaf C; Lebok P; Kutup A; Bockhorn M; Izbicki JR; Bokemeyer C; Simon R; Sauter G; Marx AH
    BMC Gastroenterol; 2015 Feb; 15():7. PubMed ID: 25649416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours.
    Lundberg A; Lindström LS; Li J; Harrell JC; Darai-Ramqvist E; Sifakis EG; Foukakis T; Perou CM; Czene K; Bergh J; Tobin NP
    Breast Cancer Res; 2019 Feb; 21(1):34. PubMed ID: 30819233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclin D1 overexpression in Algerian breast cancer women: correlation with CCND1 amplification and clinicopathological parameters.
    Mohammedi L; Doula FD; Mesli F; Senhadji R
    Afr Health Sci; 2019 Jun; 19(2):2140-2146. PubMed ID: 31656498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.
    Seiler R; Thalmann GN; Rotzer D; Perren A; Fleischmann A
    Mod Pathol; 2014 Jan; 27(1):87-95. PubMed ID: 23887292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast.
    Simpson JF; Quan DE; O'Malley F; Odom-Maryon T; Clarke PE
    Am J Pathol; 1997 Jul; 151(1):161-8. PubMed ID: 9212742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of CHK1 and CCND1 gene copy number changes in breast cancer with dual-colour fluorescence in-situ hybridization.
    Mu K; Li L; Yang Q; Zhang T; Gao P; Meng B; Liu Z; Wang Y; Zhou G
    Histopathology; 2011 Mar; 58(4):601-7. PubMed ID: 21401699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FISH is more sensitive than Southern analysis at identifying increased levels of cyclin D1 gene amplified in breast cancer cell lines.
    Dongsong N; Zhou JY
    Mol Biol Rep; 2010 Oct; 37(7):3473-80. PubMed ID: 19967453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.